CDC- BRFSS – ACBS 2020 Adult Prevalence Table 9
| State/Territory | Current | |||
|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | |
| Arizona | 312 | 36.4 | 4.2 | (28.2 – 44.6) |
| Connecticut | 294 | 38.7 | 5.0 | (28.9 – 48.5) |
| Florida | 283 | 39.5 | 5.6 | (28.5 – 50.5) |
| Georgia | 269 | 47.9 | 5.3 | (37.5 – 58.3) |
| Hawaii | 233 | 29.0 | 3.9 | (21.4 – 36.6) |
| Indiana | 290 | 48.7 | 4.1 | (40.7 – 56.7) |
| Iowa | 281 | 45.3 | 3.7 | (38.0 – 52.6) |
| Kansas | 228 | 53.2 | 4.9 | (43.6 – 62.8) |
| Maine | 395 | 51.1 | 4.6 | (42.1 – 60.1) |
| Maryland | 141 | 43.2 | 6.1 | (31.2 – 55.2) |
| Massachusetts | 235 | 45.3 | 4.7 | (36.1 – 54.5) |
| Michigan | 329 | 43.7 | 3.9 | (36.1 – 51.3) |
| Minnesota | 475 | 49.7 | 2.9 | (44.0 – 55.4) |
| Missouri | 256 | 50.6 | 4.8 | (41.2 – 60.0) |
| Montana | 236 | 46.9 | 4.5 | (38.1 – 55.7) |
| Nebraska | 418 | 47.2 | 3.8 | (39.8 – 54.6) |
| New Hampshire | 375 | 43.3 | 3.6 | (36.2 – 50.4) |
| New Jersey | 435 | 33.1 | 3.0 | (27.2 – 39.0) |
| New Mexico | 245 | 35.5 | 5.2 | (25.3 – 45.7) |
| New York | 178 | 33.5 | 4.9 | (23.9 – 43.1) |
| Ohio | 405 | 45.0 | 3.8 | (37.6 – 52.4) |
| Oregon | 233 | 45.8 | 4.0 | (38.0 – 53.6) |
| Pennsylvania | 176 | 28.3 | 5.0 | (18.5 – 38.1) |
| Rhode Island | 232 | 41.0 | 5.1 | (31.0 – 51.0) |
| Texas | 391 | 41.6 | 5.1 | (31.6 – 51.6) |
| Utah | 366 | 46.1 | 3.4 | (39.4 – 52.8) |
| Vermont | 371 | 34.5 | 3.5 | (27.6 – 41.4) |
| Wisconsin | 227 | 34.9 | 4.4 | (26.3 – 43.5) |
| Puerto Rico | 222 | 37.9 | 4.8 | (28.5 – 47.3) |
| 29 States / Area | 8,531 | 40.9 | 1.1 | (38.7 – 43.1) |
| Median | 43.3 | |||
| Range | 28.3-53.2 | |||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
± Sample size for adults with current asthma, excludes “DK/Refused”
§ Standard error
† Confidence interval
Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2020/pdf/sdq_report_acbs_20-508.pdf